NIH-funded research P01 program project

Developing advanced tools for imaging and therapy in medicine

Official title: Bioengineering core

Funded at Icahn School of Medicine at Mount Sinai · NIH-11064090 · Data updated 2026-11-12

This study is working on new ways to improve medical imaging and treatments using tiny particles that can help doctors see and treat illnesses more safely and effectively, which could lead to better care for patients like you.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$569,812
NIH project number5P01AI168258-03
Project IDNIH-11064090 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include patients undergoing treatment that requires advanced imaging or those with conditions that could be targeted by new therapeutic approaches.

Less likely to help

Patients who are not undergoing treatment that involves imaging or those with conditions outside the scope of the developed therapies may not receive benefit from this research.

What this research studies

This research focuses on creating innovative bioengineering solutions to enhance medical imaging and therapeutic interventions. It aims to develop immunity-inhibiting nanobiologics and immuno-PET probes that will streamline therapeutic experiments and improve the safety of radioactive material usage. Patients may benefit from these advancements through improved diagnostic accuracy and more effective treatments. The research will be conducted over five years, with ongoing development of new nanotherapies and imaging probes.

Why it matters

Potential benefit: If successful, this research could lead to more effective imaging techniques and therapies for various medical conditions.

How similar studies have gone: Other research in bioengineering and nanotechnology has shown promise in improving medical imaging and therapeutic outcomes, indicating a strong potential for success in this area.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Fayad, Zahi a. — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Fayad, Zahi a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.